Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Mimedx Group Inc (NASDAQ: MDXG) closed at $6.12 down -4.67% from its previous closing price of $6.42. In other words, the price has decreased by -$4.67 from its previous closing price. On the day, 0.5 million shares were traded.
Ratios:
For a deeper understanding of Mimedx Group Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.49 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.76. For the most recent quarter (mrq), Quick Ratio is recorded 4.13 and its Current Ratio is at 4.70. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 02, 2024, initiated with a Overweight rating and assigned the stock a target price of $11.
On March 07, 2024, Lake Street started tracking the stock assigning a Buy rating and target price of $12.
On October 27, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $12.Craig Hallum initiated its Buy rating on October 27, 2023, with a $12 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 02 ’25 when Capper Joseph H bought 200,000 shares for $6.34 per share. The transaction valued at 1,268,000 led to the insider holds 529,530 shares of the business.
Maersk-Moller Kimberly sold 1,759 shares of MDXG for $14,142 on Mar 17 ’25. The Chief Commercial Officer now owns 309,077 shares after completing the transaction at $8.04 per share. On Mar 13 ’25, another insider, Hulse William Frank IV, who serves as the General Counsel and CAO of the company, sold 54,596 shares for $7.89 each. As a result, the insider received 430,762 and left with 440,178 shares of the company.
Valuation Measures:
As of this moment, Mimedx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.69, and their Forward P/E ratio for the next fiscal year is 17.79. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.60. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.57 while its Price-to-Book (P/B) ratio in mrq is 4.45.
Stock Price History:
Over the past 52 weeks, MDXG has reached a high of $10.14, while it has fallen to a 52-week low of $5.47. The 50-Day Moving Average of the stock is -9.84%, while the 200-Day Moving Average is calculated to be -18.55%.
Shares Statistics:
A total of 147.61M shares are outstanding, with a floating share count of 115.99M. Insiders hold about 21.47% of the company’s shares, while institutions hold 50.32% stake in the company.
Earnings Estimates
Mimedx Group Inc (MDXG) is presently subject to a detailed evaluation by 2.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $0.06, with high estimates of $0.07 and low estimates of $0.05.
Analysts are recommending an EPS of between $0.28 and $0.26 for the fiscal current year, implying an average EPS of $0.27. EPS for the following year is $0.34, with 2.0 analysts recommending between $0.38 and $0.3.
Revenue Estimates
A total of 4 analysts believe the company’s revenue will be $90.79M this quarter.It ranges from a high estimate of $92M to a low estimate of $89.28M. As of the current estimate, Mimedx Group Inc’s year-ago sales were $87.21MFor the next quarter, 4 analysts are estimating revenue of $93.32M. There is a high estimate of $94.78M for the next quarter, whereas the lowest estimate is $91.6M.
A total of 4 analysts have provided revenue estimates for MDXG’s current fiscal year. The highest revenue estimate was $376.2M, while the lowest revenue estimate was $374M, resulting in an average revenue estimate of $374.9M. In the same quarter a year ago, actual revenue was $348.88MBased on 4 analysts’ estimates, the company’s revenue will be $417.95M in the next fiscal year. The high estimate is $430M and the low estimate is $407M.
